Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Smith K, Moody AC |
Schizophrenia and the Siamese fighting fish |
Dis. Nerv. Syst. |
1956 |
Abramson HA, Sklarofsky B... |
Production of tolerance to psychosis-produclng doses of lysergic acid ... |
Science |
1957 |
CM Smith |
A New Adjunct to the Treatment of Alcoholism: The Hallucinogenic Drug... |
Quart. J. Studies on... |
1958 |
Abramson HA, Sklarofsky A... |
Lysergic acid diethylamide (LSD-25) antagonists. II. Development of ... |
Arch. Neurol. & Psyc... |
1958 |
Smith CM |
A new adjunct to the treatment of alcoholism: The hallucinogenic drug... |
Quart. J. Alcohol |
1958 |
Bishop PO, Field G, Henne... |
Action of d-lysergic acid diethylamide on lateral geniculate synapses. |
J.Neurophysiol. |
1958 |
Baron MO, Sklarofsky B, F... |
Lysergic acid diethylamide (LSD-25): XXVIII. Assay of 2-bromo-lysergi... |
J.Psychol. |
1958 |
Baron M O, Sklarofsky B, ... |
Lysergic Acid Diethylamide (LSD-25): XXVIII. Assay of 2-Brom-Lysergic ... |
J. of Psychology |
1958 |
Hoffer A, Smith C, Chwelo... |
Psychological response to d-lysergic acid diethylamide and its relatio... |
J.Clin.Exper.Psychop... |
1959 |
Chwelos N, Blewett DB, Sm... |
Use of d-lysergic acid diethylamide in the treatment of alcoholism |
Quart. J. Stud. Alco... |
1959 |
Smith CM |
Some Reflections on the Possible Therapeutic Effects of the Hallucinog... |
Quart.J.Stud.Alcohol... |
1959 |
Smith CM, Walaszek EJ |
Interaction of lysergic acid diethylamide (LSD) with polypeptides whic... |
Fed. Proc. |
1960 |
Fremont-Smith F, Abramson... |
Introductory remarks |
The Use of LSD in Ps... |
1960 |
Smith RP |
The effect of LSD-25 and atropine upon figural after effects |
Pharmacologist |
1960 |
Walaszek EJ, Huggins CG, ... |
Antagonists of the Pharmacologically active polypeptide substance A |
Pharmacologist |
1960 |
Smith CM, Walaszek EJ |
Potentiation of Smooth Muscle Stimulants by Lysergic Acid Diethylamide... |
Fed. Proc. |
1961 |
Smith DL |
The effect of experimentally modified sleeping periods on brain levels... |
Biochem. Pharmacol. |
1961 |
Smith CM, Walaszek EJ |
Interaction of substance P and other smooth muscle stimulants with LSD... |
Arch. int. Pharmacod... |
1962 |
Cates N, Goldsmith ED, Si... |
Interrelations between the effects of endocrine organestomies and of L... |
Fed. Proc. |
1964 |
Alluisi EA, Chiles WD, Sm... |
Human Performance in Military Systems: Some Situational Factors Influe... |
Military Report |
1964 |
Leung YA, Smith AH, Paul ... |
Production of Psilocybin in Psilocybe baeocystis Saprophytic Culture |
J Pharm Sci |
1965 |
CB Alden, BH Smith, WR Ca... |
Panel Discussion: Headache |
New York J. Med. |
1966 |
Fremont-Smith F, Altschul... |
Pros and con regarding LSD. (Letters to the Editor) |
New Engl. J. Med. |
1966 |
Bozzetti L, Goldsmith S, ... |
The great banana hoax |
Ameri. J. Psychiat |
1967 |
Smith JP |
LSD: the false illusion. Part I |
FDA Papers |
1967 |
Smith DE, Rose AJ |
The use and abuse of LSD in haight-ashbury (Observations by the Haight... |
Clinical Pediatrics |
1968 |
Ungerleider JT, Fisher DD... |
A statistical survey of adverse reactions to LSD in Los Angeles county |
Amer. J. Psychiat. |
1968 |
Smith CG |
Gilles de la Tourette syndrome treated with LSD |
Irish J. Med. Sci |
1969 |
Smith DE |
Use of LSD in the Haight-Ashbury. Observations at a neighborhood clin... |
Calif. Med. |
1969 |
Richards LG, Joffe MH, Sm... |
LSD-25: A factual account. Layman's guide to the pharmacology, physiol... |
|
1969 |
Smith DE |
The Psychotomimetic Amphetamines with Special Reference to DOM (STP) T... |
Journal of Psychedel... |
1969 |
Aase JM, Laestadius N, Sm... |
Children of mothers who took L.S.D. in pregnancy |
Lancet |
1970 |
Hartley R, Smith JA |
The activation of pineal hydroxyndole-O-methyltransferase by psychotom... |
J. Pharm. Pharmcol. |
1973 |
Smith RC, Boggan WO, Free... |
Effects of Single and Multiple Dose LSD on Endogenous Levels of Brain ... |
Psychopharmacologia |
1975 |
Smith SJ |
Effects Of Psychotropic Drugs On Brain Nuclear RNA |
Psychopharmacology B... |
1975 |
Wesson DR, Smith DE |
An analysis of psychedelic drug flashbacks |
Am J Drug Alcohol Ab... |
1976 |
Smithells RW |
Environmental Teratogens Of Man |
Brit.med.Bull. |
1976 |
Smith JM, Misiak H |
Critical Flicker Frequency (CFF) and Psychotropic Drugs in Normal Huma... |
Psychopharmacology |
1976 |
Wesson DR, Smith DE |
An Analysis Of Psychedelic Drug Flashbacks |
Amer. J. Drug Alcoho... |
1976 |
Domelsmith LN, Munchhause... |
Lysergic Acid Diethylamide. Photoelectron Ionization Potentials as Ind... |
J.Med.Chem. |
1977 |
Domelsmith LN, Munchhause... |
Photoelectron Spectra of Psychotropic Drugs. 1. Phenethylamines, Trypt... |
J.Am.Chem.Soc. |
1977 |
Smith TA |
Phenethylamine and related compounds in plants |
Phytochemistry |
1977 |
Siddik ZH, Barnes RD, Dri... |
The fate of lysergic acid di[14C]ethylamide ([14C]LSD) in the rat, gui... |
Biochemical Pharmaco... |
1979 |
Siddik ZH, Barnes RD, Dri... |
The metabolism of lysergic acid diethylamide (LSD) in the isolated per... |
Biochem. Pharmacol. |
1979 |
Smith JA, Walters G, John... |
LSD "flashback" as a cause of diagnostic error |
Postgrad. med. J. |
1980 |
Domelsmith LN, Eaton TA, ... |
Photoelectron spectra of psychotropic drugs. 6. Relationships between ... |
J Med Chem |
1981 |
Monroe PJ, Smith DJ |
Characterization of Multiple [3H]5-Hydroxytryptamine Binding Sites in ... |
J. Neurochem. |
1983 |
Smith LAC, Meyerson BJ |
Influence of Long-term Zimeldine Treatment on LSD-induced Behavioural ... |
Actapharmacol et tox... |
1984 |
Geaney DP, Schachter M, E... |
Characterisation of [3H]Lysergic Acid Diethylamide Binding to a 5-Hydr... |
Europ J Pharmacol |
1984 |
Schachter M, Geaney DP, G... |
Increased platelet membrane [3H]-LSD binding in patients on chronic ne... |
Br. J. Clin. Pharmac... |
1985 |
Monroe PJ, Smith DJ |
Demonstration of an Autoreceptor Modulating the Release of [3h]5-hydro... |
J. Neurochem. |
1985 |
Fysh RR, Oon MC, Robinson... |
A fatal poisoning with LSD |
Forensic Sci Int |
1985 |
Seymour RB, Wesson DR, Sm... |
MDMA (3,4-methylenedioxymethamphetamine): proceedings of the conferenc... |
J Psychoactive Drugs |
1986 |
Seymour RB, Wesson DR, Sm... |
Editor's Introduction |
J Psychoactive Drugs |
1986 |
Smith DE, Wesson DR, Sees... |
An epidemiological and clinical analysis of propylhexedrine abuse in t... |
J Psychoactive Drugs |
1988 |
Pemberton IJ, Smith GR, F... |
Technical note: an improved method for extraction and quantification o... |
J Anim Sci |
1993 |
Smith DE, Seymour RB |
LSD: History and Toxicity |
Psychiatric Annals |
1994 |
Marsh JCW, Abboudi ZH, Gi... |
Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetami... |
Br J Haematol |
1994 |
Smith ML, Hughes RO, Levi... |
Forensic drug testing for opiates. VI. Urine testing for hydromorphone... |
J Anal Toxicol |
1995 |
Dyzkuizen RS, Brunt PW, A... |
Ecstasy induced hepatitis mimicking viral hepatitis |
Gut |
1995 |
Kunsman GW, Levine B, Kuh... |
MDA-MDMA concentrations in urine specimens |
J Anal Toxicol |
1996 |
Hirst M, Smith MT, Crouch... |
Psychoactive Constituents of the Genus Sceletium N.E.Br. andOther Mese... |
Journal of Ethnopha... |
1996 |
Smith MT, Crouch NR, Geri... |
Psychoactive constituents of the genus Sceletium N.E.Br. and other Mes... |
J Ethnopharmacol |
1996 |
Calhoun SR, Wesson DR, Ga... |
Abuse of flunitrazepam Rohypnol and other benzodiazepines in Austin an... |
J Psychoactive Drugs |
1996 |
Moore KA, Kilbane EM, Jon... |
Tissue distribution of ketamine in a mixed drug fatality |
J Forensic Sci |
1997 |
Gervin M, Smith R, Bamfor... |
Chasing the dragon: experience in Ireland and association with 'Ecstas... |
Addiction |
1998 |
Tagliaro F, Manetto G, Be... |
Simultaneous chiral separation of 3,4-methylenedioxymethamphet- amine,... |
Electrophoresis |
1998 |
Meltzer CC, Smith G, DeKo... |
Serotonin in Aging, Late-Life Depression, and Alzheimer’s Disease: The... |
Neuropsychopharmacol... |
1998 |
Smith FL, Cichewicz D, Ma... |
The enhancement of morphine antinociception in mice by delta9-tetrahyd... |
Pharmacol Biochem Be... |
1998 |
Smith RL, Canton H, Barre... |
Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5... |
Pharmacol Biochem Be... |
1998 |
Hammersley R, Ditton J, S... |
Patterns of ecstasy use by drug users |
British Journal of C... |
1999 |
Kidwell DA, Smith FP |
Susceptibility of PharmChek Drugs of Abuse Patch to Environmental Cont... |
Naval Research Labor... |
1999 |
Cooper GA, Allen DL, Scot... |
Hair analysis: self-reported use of 'speed' and 'ecstasy' compared wit... |
J Forensic Sci |
2000 |
Dowd CS, Herrick-Davis K,... |
1-[4-3-Phenylalkylphenyl]-2-aminopropanes as 5-HT2A partial agonists |
J Med Chem |
2000 |
Macleod J, Davey Smith G,... |
Psychological stress and cardiovascular disease: empirical demonstrati... |
BMJ |
2002 |
Smith KM, Larive LL, Roma... |
Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hyd... |
Am J Health Syst Pha... |
2002 |
Badon LA, Hicks A, Lord K... |
Changes in Cardiovascular Responsiveness and Cardiotoxicity Elicited d... |
J Pharmacol Exp Ther |
2002 |
Smith A |
Effects of caffeine on human behavior |
Food Chem Toxicol |
2002 |
Romanelli F, Smith KM, Po... |
Use of club drugs by HIV-seropositive and HIV-seronegative gay and bis... |
Top HIV Med |
2003 |
Eckler JR, Chang-Fong J, ... |
Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabol... |
Pharmacol Biochem Be... |
2003 |
Iravani MM, Jackson MJ, ... |
3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expres... |
The Journal of Neuro... |
2003 |
Macleod J, Oakes R, Copel... |
Psychological and social sequelae of cannabis and other illicit drug u... |
Lancet |
2004 |
Gresch PJ, Smith RL, Barr... |
Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with ... |
Neuropsychopharmacol... |
2005 |
Smith HM, Chiszar D |
Dilemma of Name-Recognition: Why and When to Use New Combinations of S... |
Herpetological Conse... |
2006 |
Tanner-Smith EE |
Pharmacological content of tablets sold as 'ecstasy': results from an ... |
Drug Alcohol Depend |
2006 |
Benneyworth MA, Xiang Z, ... |
A selective positive allosteric modulator of metabotropic glutamate re... |
Mol Pharmacol |
2007 |
Tanner-Smith EE |
Corrigendum to 'Pharmacological content of tablets sold as 'ecstasy': ... |
Drug Alcohol Depend |
2008 |
LeTourneau JL, Hagg DS, S... |
Baclofen and gamma-hydroxybutyrate withdrawal |
Neurocrit Care |
2008 |
Appendino G, Gibbons S, G... |
Antibacterial cannabinoids from Cannabis sativa: a structure-activity ... |
J Nat Prod |
2008 |
Bloor RN, Wang TS, Spanel... |
Ammonia release from heated 'street' cannabis leaf and its potential t... |
Addiction |
2008 |
Smith Z, Moore K, Measham... |
MDMA powder, pills and crystal: the persistence of ecstasy and the pov... |
Drugs and Alcohol To... |
2009 |
Davies S, Wood DM, Smith ... |
Purchasing 'legal highs' on the Internet--is there consistency in what... |
QJM |
2010 |
Du Mont J, Macdonald S, R... |
Drug-facilitated sexual assault in Ontario, Canada: toxicological and ... |
J Forensic Leg Med |
2010 |
Hart CL, Marvin CB, Silve... |
Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical... |
Neuropsychopharmacol... |
2011 |
Sanacora G, Smith MA, Pat... |
Lanicemine: a low-trapping NMDA channel blocker produces sustained ant... |
Mol Psychiatry |
2013 |
Seely KA, Patton AL, Mora... |
Forensic investigation of K2, Spice, and bath salt commercial preparat... |
Forensic Sci Int |
2013 |
Smith JP, Metters JP, Irv... |
Forensic electrochemistry: the electroanalytical sensing of synthetic ... |
Analyst |
2014 |
Elston TW, Pandian A, Smi... |
Aniracetam does not alter cognitive and affective behavior in adult C5... |
PLoS One |
2014 |
Hope VD, Cullen KJ, Smith... |
Is the recent emergence of mephedrone injecting in the United Kingdom ... |
Euro Surveill |
2016 |
Elliott SP, Brandt SD, Sm... |
The first reported fatality associated with the synthetic opioid 3,4-d... |
Drug Test Anal |
2016 |